Listed

Haemonetics Corp

HAENYSECIK 313143HealthcareFiscal year ends Apr 3

Latest reported revenue, Q1 FY2027$339.4mRevenue, Q1 FY2027, three months to 2026-06-27$339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figureThree months to Jun 27, 2026, from the 10-Q filed Aug 6, 2026.

Latest quarter: Q1 FY2027

Three months to Jun 27, 2026, against the same quarter a year earlier.

  • Revenue$339.4mRevenue, Q1 FY2027, three months to 2026-06-27$339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure+5.6% on a year earlier
  • Gross margin59.8%Gross margin, Q1 FY2027, three months to 2026-06-27. gross profit / revenueGross profit: $202.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure−0.1 pts on a year earlier
  • Operating margin16.9%Operating margin, Q1 FY2027, three months to 2026-06-27. operating income / revenueOperating income: $57.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure+0.2 pts on a year earlier
  • Net margin9.7%Net margin, Q1 FY2027, three months to 2026-06-27. net income / revenueNet income: $33.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure−0.9 pts on a year earlier
  • Diluted EPS$0.72Diluted EPS, Q1 FY2027, three months to 2026-06-27$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure+2.9% on a year earlier
  • Free cash flow$44.4mFree cash flow, Q1 FY2027, three months to 2026-06-27. operating cash flow − capital expenditureOperating cash flow: $52.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Capital expenditure: $7.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure+225.6% on a year earlier

Last eight quarters

Full statements
Revenue$339.4mGross margin 59.8%
Diluted EPS$0.72, Q1 FY2027
Free cash flow$44.4m, Q1 FY2027
Haemonetics Corp, key figures for the last eight quarters
Line itemUnitQ2 FY20252024-09-28Q3 FY20252024-12-28Q4 FY20252025-03-29Q1 FY20262025-06-28Q2 FY20262025-09-27Q3 FY20262025-12-27Q4 FY20262026-03-28Q1 FY20272026-06-27Shape over the periods
Revenue$m346Revenue, Q2 FY2025, three months to 2024-09-28$345.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure349Revenue, Q3 FY2025, three months to 2024-12-28$348.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure331Revenue, Q4 FY2025, three months to 2025-03-29$330.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure321Revenue, Q1 FY2026, three months to 2025-06-28$321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure327Revenue, Q2 FY2026, three months to 2025-09-27$327.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure339Revenue, Q3 FY2026, three months to 2025-12-27$339.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure346Revenue, Q4 FY2026, three months to 2026-03-28$346.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure339Revenue, Q1 FY2027, three months to 2026-06-27$339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure
Gross margin%54.2%Gross margin, Q2 FY2025, three months to 2024-09-28. gross profit / revenueGross profit: $187.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Revenue: $345.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure55.5%Gross margin, Q3 FY2025, three months to 2024-12-28. gross profit / revenueGross profit: $193.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $348.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure58.4%Gross margin, Q4 FY2025, three months to 2025-03-29. gross profit / revenueGross profit: $193.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Revenue: $330.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure59.8%Gross margin, Q1 FY2026, three months to 2025-06-28. gross profit / revenueGross profit: $192.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure59.5%Gross margin, Q2 FY2026, three months to 2025-09-27. gross profit / revenueGross profit: $194.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Revenue: $327.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure59.7%Gross margin, Q3 FY2026, three months to 2025-12-27. gross profit / revenueGross profit: $202.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $339.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure57.2%Gross margin, Q4 FY2026, three months to 2026-03-28. gross profit / revenueGross profit: $198.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Revenue: $346.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure59.8%Gross margin, Q1 FY2027, three months to 2026-06-27. gross profit / revenueGross profit: $202.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure
Operating margin%15.0%Operating margin, Q2 FY2025, three months to 2024-09-28. operating income / revenueOperating income: $51.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Revenue: $345.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure16.9%Operating margin, Q3 FY2025, three months to 2024-12-28. operating income / revenueOperating income: $59.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $348.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure21.6%Operating margin, Q4 FY2025, three months to 2025-03-29. operating income / revenueOperating income: $71.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Revenue: $330.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure16.8%Operating margin, Q1 FY2026, three months to 2025-06-28. operating income / revenueOperating income: $53.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure17.9%Operating margin, Q2 FY2026, three months to 2025-09-27. operating income / revenueOperating income: $58.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Revenue: $327.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure19.9%Operating margin, Q3 FY2026, three months to 2025-12-27. operating income / revenueOperating income: $67.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $339.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure(6.6%)Operating margin, Q4 FY2026, three months to 2026-03-28. operating income / revenueOperating income: −$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Revenue: $346.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure16.9%Operating margin, Q1 FY2027, three months to 2026-06-27. operating income / revenueOperating income: $57.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure
Net margin%9.8%Net margin, Q2 FY2025, three months to 2024-09-28. net income / revenueNet income: $33.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $345.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure10.8%Net margin, Q3 FY2025, three months to 2024-12-28. net income / revenueNet income: $37.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $348.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure17.5%Net margin, Q4 FY2025, three months to 2025-03-29. net income / revenueNet income: $58.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Revenue: $330.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure10.6%Net margin, Q1 FY2026, three months to 2025-06-28. net income / revenueNet income: $34.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $321.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure11.8%Net margin, Q2 FY2026, three months to 2025-09-27. net income / revenueNet income: $38.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $327.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure13.2%Net margin, Q3 FY2026, three months to 2025-12-27. net income / revenueNet income: $44.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Revenue: $339.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figure(5.8%)Net margin, Q4 FY2026, three months to 2026-03-28. net income / revenueNet income: −$20.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Revenue: $346.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure9.7%Net margin, Q1 FY2027, three months to 2026-06-27. net income / revenueNet income: $33.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Revenue: $339.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure
Diluted EPS$ per share0.66Diluted EPS, Q2 FY2025, three months to 2024-09-28$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure0.74Diluted EPS, Q3 FY2025, three months to 2024-12-28$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figurenot reported (Diluted EPS not reported)0.70Diluted EPS, Q1 FY2026, three months to 2025-06-28$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure0.81Diluted EPS, Q2 FY2026, three months to 2025-09-27$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000313143-25-000075.Report this figure0.95Diluted EPS, Q3 FY2026, three months to 2025-12-27$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-05, accession 0000313143-26-000010.Report this figurenot reported (Diluted EPS not reported)0.72Diluted EPS, Q1 FY2027, three months to 2026-06-27$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure
Free cash flow$m39.4Free cash flow, Q2 FY2025, three months to 2024-09-28. operating cash flow − capital expenditureOperating cash flow: $48.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000313143-25-000075. Derived: 6-month figure less the 3-month figure.Capital expenditure: $9.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000313143-25-000075. Derived: 6-month figure less the 3-month figure.Report this figure35.2Free cash flow, Q3 FY2025, three months to 2024-12-28. operating cash flow − capital expenditureOperating cash flow: $43.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0000313143-26-000010. Derived: 9-month figure less the 6-month figure.Capital expenditure: $8.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0000313143-26-000010. Derived: 9-month figure less the 6-month figure.Report this figure101Free cash flow, Q4 FY2025, three months to 2025-03-29. operating cash flow − capital expenditureOperating cash flow: $116.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Capital expenditure: $15.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure13.6Free cash flow, Q1 FY2026, three months to 2025-06-28. operating cash flow − capital expenditureOperating cash flow: $17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure106Free cash flow, Q2 FY2026, three months to 2025-09-27. operating cash flow − capital expenditureOperating cash flow: $111.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000313143-25-000075. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000313143-25-000075. Derived: 6-month figure less the 3-month figure.Report this figure87.2Free cash flow, Q3 FY2026, three months to 2025-12-27. operating cash flow − capital expenditureOperating cash flow: $93.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0000313143-26-000010. Derived: 9-month figure less the 6-month figure.Capital expenditure: $6.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0000313143-26-000010. Derived: 9-month figure less the 6-month figure.Report this figure53.3Free cash flow, Q4 FY2026, three months to 2026-03-28. operating cash flow − capital expenditureOperating cash flow: $70.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Capital expenditure: $17.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0000313143-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure44.4Free cash flow, Q1 FY2027, three months to 2026-06-27. operating cash flow − capital expenditureOperating cash flow: $52.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Capital expenditure: $7.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0000313143-26-000120.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.33bnGross margin 59.0%
Diluted EPS$2.05, FY2026
Free cash flow$260.4m, FY2026
Haemonetics Corp, key figures for the last five fiscal years
Line itemUnitFY20222022-04-02FY20232023-04-01FY20242024-03-30FY20252025-03-29FY20262026-03-28Shape over the periods
Revenue$m993Revenue, FY2022, twelve months to 2022-04-02$993.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-20, accession 0000313143-24-000020.Report this figure1,169Revenue, FY2023, twelve months to 2023-04-01$1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-21, accession 0000313143-25-000025.Report this figure1,309Revenue, FY2024, twelve months to 2024-03-30$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure1,361Revenue, FY2025, twelve months to 2025-03-29$1.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure1,334Revenue, FY2026, twelve months to 2026-03-28$1.33bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure
Gross margin%50.9%Gross margin, FY2022, twelve months to 2022-04-02. gross profit / revenueGross profit: $505.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-05-20, accession 0000313143-24-000020.Revenue: $993.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-20, accession 0000313143-24-000020.Report this figure52.6%Gross margin, FY2023, twelve months to 2023-04-01. gross profit / revenueGross profit: $615.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-05-21, accession 0000313143-25-000025.Revenue: $1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-21, accession 0000313143-25-000025.Report this figure52.8%Gross margin, FY2024, twelve months to 2024-03-30. gross profit / revenueGross profit: $691.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure55.0%Gross margin, FY2025, twelve months to 2025-03-29. gross profit / revenueGross profit: $749.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure59.0%Gross margin, FY2026, twelve months to 2026-03-28. gross profit / revenueGross profit: $787.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.33bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure
Operating margin%8.1%Operating margin, FY2022, twelve months to 2022-04-02. operating income / revenueOperating income: $80.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-05-20, accession 0000313143-24-000020.Revenue: $993.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-20, accession 0000313143-24-000020.Report this figure13.4%Operating margin, FY2023, twelve months to 2023-04-01. operating income / revenueOperating income: $156.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-05-21, accession 0000313143-25-000025.Revenue: $1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-21, accession 0000313143-25-000025.Report this figure12.6%Operating margin, FY2024, twelve months to 2024-03-30. operating income / revenueOperating income: $164.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure16.3%Operating margin, FY2025, twelve months to 2025-03-29. operating income / revenueOperating income: $221.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure11.7%Operating margin, FY2026, twelve months to 2026-03-28. operating income / revenueOperating income: $156.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.33bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure
Net margin%4.4%Net margin, FY2022, twelve months to 2022-04-02. net income / revenueNet income: $43.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-05-20, accession 0000313143-24-000020.Revenue: $993.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-05-20, accession 0000313143-24-000020.Report this figure9.9%Net margin, FY2023, twelve months to 2023-04-01. net income / revenueNet income: $115.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-05-21, accession 0000313143-25-000025.Revenue: $1.17bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-05-21, accession 0000313143-25-000025.Report this figure9.0%Net margin, FY2024, twelve months to 2024-03-30. net income / revenueNet income: $117.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure12.3%Net margin, FY2025, twelve months to 2025-03-29. net income / revenueNet income: $167.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure7.3%Net margin, FY2026, twelve months to 2026-03-28. net income / revenueNet income: $97.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-05-20, accession 0000313143-26-000050.Revenue: $1.33bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure
Diluted EPS$ per share0.84Diluted EPS, FY2022, twelve months to 2022-04-02$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-05-20, accession 0000313143-24-000020.Report this figure2.24Diluted EPS, FY2023, twelve months to 2023-04-01$2.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-05-21, accession 0000313143-25-000025.Report this figure2.29Diluted EPS, FY2024, twelve months to 2024-03-30$2.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure3.31Diluted EPS, FY2025, twelve months to 2025-03-29$3.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure2.05Diluted EPS, FY2026, twelve months to 2026-03-28$2.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure
Free cash flow$m75.8Free cash flow, FY2022, twelve months to 2022-04-02. operating cash flow − capital expenditureOperating cash flow: $172.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-05-20, accession 0000313143-24-000020.Capital expenditure: $96.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-05-20, accession 0000313143-24-000020.Report this figure81.7Free cash flow, FY2023, twelve months to 2023-04-01. operating cash flow − capital expenditureOperating cash flow: $273.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-05-21, accession 0000313143-25-000025.Capital expenditure: $191.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-05-21, accession 0000313143-25-000025.Report this figure144Free cash flow, FY2024, twelve months to 2024-03-30. operating cash flow − capital expenditureOperating cash flow: $181.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0000313143-26-000050.Capital expenditure: $38.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure142Free cash flow, FY2025, twelve months to 2025-03-29. operating cash flow − capital expenditureOperating cash flow: $181.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0000313143-26-000050.Capital expenditure: $39.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure260Free cash flow, FY2026, twelve months to 2026-03-28. operating cash flow − capital expenditureOperating cash flow: $293.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-20, accession 0000313143-26-000050.Capital expenditure: $32.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-20, accession 0000313143-26-000050.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Haemonetics Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$443.2m5,909,258Added+289,279
NEUBERGER BERMAN GROUP LLC2026-06-30$313.5m4,179,443Added+618,525
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$191.0m2,546,394Reduced−12,922
AQR CAPITAL MANAGEMENT LLC2026-06-30$165.0m2,266,489Reduced−1,090,054
ARIEL INVESTMENTS, LLC2026-06-30$154.6m2,060,966New+2,060,966
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$154.5m2,059,578Reduced−30,811
STATE STREET CORP2026-06-30$136.4m1,818,186Added+45,288
DIMENSIONAL FUND ADVISORS LP2026-06-30$118.9m1,585,222Added+259,165
CITADEL ADVISORS LLC2026-06-30$113.3m1,510,120Added+1,251,967
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$96.6m1,287,240Added+68,262

Recent filings

All 1,382 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Haemonetics Corp, recent filings
FiledFormWhat it isAccession number
2026-10-0810:15 ET8-K7.01 Regulation FD disclosure0000313143-26-000138
2026-08-1810:03 ET8-K7.01 Regulation FD disclosure0000313143-26-000135
2026-08-0610:09 ET10-QQuarterly reportPeriod 2026-06-270000313143-26-000120
2026-08-0610:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000313143-26-000118
2026-07-2820:28 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000313143-26-000095
2026-06-0920:17 ETDEF 14AProxy statementPeriod 2026-03-280000313143-26-000074
2026-06-0510:33 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000313143-26-000057
2026-05-2010:31 ET10-KAnnual reportPeriod 2026-03-280000313143-26-000050
2026-05-0710:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000313143-26-000031
2026-05-0120:18 ET8-K5.02 Departure or appointment of officers or directors0000313143-26-000023

Latest annual report

Form 10-K for the fiscal year ended Mar 28, 2026Filed May 20, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q2 FY2027, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
313143
Tickers
HAE
Exchange
NYSE
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Apr 3
Incorporated in
MA
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. Listed shows no prices and gives no investment advice.